论文部分内容阅读
１９９９年１～９月，我们对３０例在我科住院的急性脑梗死患者用龙津降纤酶治疗，现就其疗效及安全性报告如下。１材料与方法１．１病例选择采用 １９９５年全国脑血管病学术会议统一诊断标准，入选６０例脑梗死患者，随机分为两组：治疗组３０例，其中男１７例，女１３例，年
From January to September 1999, we treated 30 patients with acute cerebral infarction who were hospitalized in our department with Longjin defibrase, and the efficacy and safety of these drugs are reported below. 1 Materials and Methods 1.1 Case Selection The 1995 National Conference on cerebrovascular disease diagnostic criteria, selected 60 patients with cerebral infarction were randomly divided into two groups: the treatment group of 30 patients, 17 males and 13 females,